Metabolic syndrome: Its link with motor function of Parkinson’s disease (PD)
Objective: To evaluate if metabolic risk factors can affect the motor function of PD patients Background: The etiology of PD remains unclear. It has been…Anti-synuclein alpha antibodies and IL-1β at Parkinson Disease (PD).
Objective: Determine a correlation between the levels of anti-synuclein alpha antibodies and IL-1β at serum and CSF of patients with PD. Background: PD is a…Atypical and slowly progressive FTDP-17 caused by MAPT p.R406W mutations – similarities to AD and PSP.
Objective: We compiled clinical data of a new kindred with the MAPT c.1216C>T (p.Arg406Trp; R406W) mutation and systematically reviewed previously described cases with this mutation.…Validation of actigraphy-derived sleep metrics in Parkinson’s disease (PD) patients and elderly controls, taking into account clinical and physiological status
Objective: To developed a novel sleep quantification method using raw actigraphy data from well characterized PD subjects and elderly controls with overnight PSG and home…A qualitative study of the views and experience of people with Parkinson’s disease regarding their footwear
Objective: A qualitative study to determine what people with Parkinson’s disease (PD) wear on their feet at home and outdoors and to increase our understanding…Rapidly progressive dementia and parkinsonism caused by a cortical dural AV fistula: a case report
Objective: To report the case of a 75-year-old woman with rapidly progressive dementia and parkinsonism caused by a cortical dural AV fistula Background: Vascular malformations…Decisional capacity for Goals of Care in Parkinson’s Disease with Cognitive Concerns
Objective: We sought to assess decisional capacity (DC) for Goals of Care (GOC) using the MacArthur Competence Assessment Tool (MacCAT) for Parkinson’s disease (PD) patients…Effects of continuous apomorphine infusion on motor and nonmotor symptoms in Parkinson’s disease without cognitive deterioration
Objective: The aim of the present study was to investigate the influence of apomorphine pump in Parkinson’s disease (PD) on motor and nonmotor symptoms, including…Mitochondrial DNA variants function as potential genetic risk factors for Parkinson disease
Objective: To understand whether mtDNA variants contribute to the susceptibility to sporadic PD. Background: It is well-recognized that mitochondrial (mt) dysfunction is involved in the…Characterization of Noncoding Variant(s) Driving Genome-Wide Association of the PARK10 Locus in Autopsy-Proven Parkinson Disease and Controls.
Objective: Confirm the PARK10 locus as a major GWAS locus in autopsy-confirmed (AC) PD and AC controls and identify potential noncoding variants driving the association. …
- « Previous Page
- 1
- …
- 291
- 292
- 293
- 294
- 295
- …
- 405
- Next Page »